Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: Patterns of failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: Patterns of failure

Published:2011-11 Issue:2 Volume:101 Page:245-249
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Andratschke Nicolaus,Zimmermann Frank,Boehm Eva,Schill Sabine,Schoenknecht Christine,Thamm Reinhard,Molls Michael,Nieder Carsten,Geinitz Hans

Funder

Bavarian State Ministry of Environment, Public Health and Consumer Protection

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference29 articles.

1. Early Lung Cancer Action Project: overall design and findings from baseline screening;Henschke;Lancet,1999

2. Survival of patients with stage I lung cancer detected on CT screening;Henschke;N Engl J Med,2006

3. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy;Baumann;J Clin Oncol,2009

4. Stage I nonsmall cell lung cancer in patients aged > or =75years: outcomes after stereotactic radiotherapy;Haasbeek;Cancer,2010

5. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC);Hof;Cancer,2007

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma;Radiotherapy and Oncology;2024-06

2. Influence de l’immunothérapie sur le choix du traitement des cancers bronchiques non à petites cellules de stade I : point de vue de l’oncologue radiothérapeute;Cancer/Radiothérapie;2023-09

3. Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer;Cost Effectiveness and Resource Allocation;2023-07-28

4. Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study;Translational Lung Cancer Research;2023-06

5. Harmonization of dose prescription for lung stereotactic radiotherapy;Physics and Imaging in Radiation Oncology;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3